The Cath Labs Services Market was $17.2 Bn in 2020, and it is expected to reach $29.6 Bn by 2031. It is eventually growing at a commendable high compound annual growth rate CAGR of 4.9% between 2021-2031. But due to the current COVID-19 pandemic, there might be a slight difference in the growth rate in the present year. Increased demand for cardiac catheterization facilities and the increased prevalence of cardiovascular diseases in this country will help to accelerate the growth of this market during the forecasted period.
Cath Labs Services Market Is Estimated To Witness Remarkable Growth
Source: SAI Research
The Cath Labs Services Market has been segmented into component and facility type. On the basis of component Cath Labs Services Market has been segmented into Services (Therapeutic [Angioplasty, Stent Placement, Rotational Atherectomy, Thrombectomy, Cardioversion, Transcatheter aortic valve replacement (TAVR), Others]), Diagnostic [Angiography, Coronary Intravascular Ultrasound, Cardiac Catheterization, ECG/EKG, Fractional Flow Reserve (FFR), Others), Equipment. On the basis of facility type, it has been segmented into Independent Labs, Hospital-Based Labs.
Major Players in Cath Labs Services Market
Some of the major players in the Cath Labs Services Market include Koninklijke Philips N.V., Shimadzu Corporation, GE Healthcare, Johnson & Johnson, B. Braun Melsungen AG, Siemens Healthineers, Medtronic.
The Global Cath Labs Services Market Has Been Segmented Into:
Global Cath Labs Services Market, By Component Type
Global Cath Labs Services Market, By Facility Type
Global Cath Labs Services Market, By Region